Skip to content
Maui Sky – Lifestyle
Author:
Elephas
ELEPHAS PUBLISHES PEER-REVIEWED DATA IN CELL REPORTS MEDICINE DEMONSTRATING elive™ PLATFORM’S IMMUNOTHERAPY RESPONSE MEASUREMENT
October 15, 2026
ELEPHAS BIOSCIENCES AND TES PHARMA COLLABORATE TO ADVANCE TRANSLATIONAL RESEARCH FOR LUNG CANCER THERAPY
September 24, 2026
ELEPHAS BIOSCIENCES ANNOUNCES EXCLUSIVE COMMERCIAL PARTNERSHIP IN INDIA WITH NEUBERG DIAGNOSTICS
August 13, 2026
ELEPHAS PRESENTS NEW DATA SHOWING elive™ PLATFORM MEASURES CYTOTOXICITY ENDPOINTS IN TARGETED THERAPIES, EXTENDING PLATFORM’S POWER
July 24, 2026
ELEPHAS ANNOUNCES COMMERCIAL PARTNERSHIP WITH INVITROCUE TO EXPAND PERSONALIZED ONCOLOGY IN SOUTHEAST ASIA
July 21, 2026
ELEPHAS BIOSCIENCES WELCOMES HOWARD A. ‘SKIP’ BURRIS III, MD TO THE COMPANY’S BOARD OF DIRECTORS
July 9, 2026